Testing effectiveness (Phase 2)Study completedNCT02076633What this trial is testingIntratumoral Administration of L19IL2/L19TNFWho this might be right forMalignant Melanoma, Skin Philogen S.p.A. 21
Testing effectiveness (Phase 2)WithdrawnNCT01216787What this trial is testingRO4929097 in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma That Can Be Removed by SurgeryWho this might be right forStage IIIB MelanomaStage IIIC MelanomaStage IV Melanoma National Cancer Institute (NCI)
Not applicableStudy completedNCT03518814What this trial is testingQuality of Life in Patients With Multimetastatic Melanoma Currently in Remission (QUALM)Who this might be right forMelanoma (Skin) Stage IVRemission Lille Catholic University 40
Large-scale testing (Phase 3)Ended earlyNCT00020839What this trial is testingTemozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the BrainWho this might be right forMelanoma (Skin)Metastatic Cancer European Organisation for Research and Treatment of Cancer - EORTC 23
Testing effectiveness (Phase 2)Study completedNCT01133977What this trial is testingE7080 (Lenvatinib) in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV MelanomaWho this might be right forStage IV Melanoma Eisai Inc. 97
Testing effectiveness (Phase 2)Looking for participantsNCT03340129What this trial is testingAnti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)Who this might be right forMelanoma Stage Iv Melanoma Institute Australia 218
Testing effectiveness (Phase 2)Study completedNCT04526899What this trial is testingInvestigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of TreatmentWho this might be right forMelanoma Stage IIIMelanoma Stage IVUnresectable Melanoma BioNTech SE 184
Early research (Phase 1)Study completedNCT00349206What this trial is testingSorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable MelanomaWho this might be right forMelanomaRecurrent MelanomaStage III Melanoma+1 more National Cancer Institute (NCI) 69
Testing effectiveness (Phase 2)UnknownNCT00085397What this trial is testingVaccine Therapy in Treating Patients With Stage III or Stage IV MelanomaWho this might be right forMelanoma (Skin) Dana-Farber Cancer Institute 40
Early research (Phase 1)Looking for participantsNCT07476326What this trial is testingPharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With MelanomaWho this might be right forMelanoma Biocon Biologics UK PLC 120
Testing effectiveness (Phase 2)Study completedNCT00387751What this trial is testingBevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant MelanomaWho this might be right forRecurrent MelanomaStage III Skin MelanomaStage IV Skin Melanoma National Cancer Institute (NCI) 14
Not applicableWithdrawnNCT00378781What this trial is testingHeparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related InfectionWho this might be right forCancer M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00089063What this trial is testingVaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for MelanomaWho this might be right forCiliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+6 more National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Ended earlyNCT01082887What this trial is testingImmunotherapy With TIL (Tumor Infiltrating Lymphocytes) in Combination With Intra-tumoral Injections of Interferon Gamma-adenovirus (Ad-IFNg) in Patients With Stage IIIc or Stage IV Metastatic Melanoma (AJCC)(Protocol TIL-Ad-INFg)Who this might be right forMetastatic Melanoma Nantes University Hospital 18
Large-scale testing (Phase 3)Study completedNCT00091572What this trial is testingTemozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267)Who this might be right forMelanoma Merck Sharp & Dohme LLC 859
Not applicableActive Not RecruitingNCT03605771What this trial is testingDescriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in SpainWho this might be right forMelanoma Stage IvMelanoma Stage IiiAdvanced Cancer Grupo Español Multidisciplinar de Melanoma 400
Large-scale testing (Phase 3)UnknownNCT00039234What this trial is testingInterleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the LiverWho this might be right forMelanoma (Skin)Metastatic Cancer Maxim Pharmaceuticals
Testing effectiveness (Phase 2)WithdrawnNCT05496192What this trial is testingNivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder CancerWho this might be right forMelanomaUrothelial Carcinoma Bristol-Myers Squibb
Very early researchStudy completedNCT04752267What this trial is testing18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain MetastasesWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Glioma+17 more University of Southern California 10
Not applicableLooking for participantsNCT07302607What this trial is testingPredictive Factors of Complete Response to Immunotherapy in Metastatic Melanoma: a Single-center Retrospective Study Between 2013 and 2021Who this might be right forStage III Melanoma University Hospital, Strasbourg, France 221